Wednesday, May 9, 2012
Should The FDA Monitor The Cosmetic Industry?
Rep. Leonard Lance (R-7th Dist.) held a press conference at L'Oreal USA's headquarters this week to rally support for his Cosmetic Safety Amendments Acts of 2012 (HR 4395). The bill, which makes the voluntary measures the Food and Drug Administration has been using to monitor the cosmetics industry mandatory. This includes activities such as registering manufacturing facilities or tracking ingredients in products. The goal is to regulate cosmetics products without placing an undue burden on the industry.